Experimental cholesterol drug fails to prevent heart attacks, strokes

Summary of 2 reports
An experimental drug that successfully lowered cholesterol levels failed to prevent heart attacks or strokes in clinical trials, contrary to researchers' expectations. Despite the drug's effectiveness at reducing this risk factor, the medication showed no measurable impact on patient outcomes.
Full coverage
The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke (opens NBC News in a new tab)
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.
A promising new medicine against heart disease fails unexpectedly (opens NPR in a new tab)
Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.

